Literature DB >> 27440391

Family Planning in Substance Use Disorder Treatment Centers: Opportunities and Challenges.

Natanya Robinowitz1, Sadiya Muqueeth2, Jill Scheibler3, Elizabeth Salisbury-Afshar4, Mishka Terplan1.   

Abstract

BACKGROUND: Alcohol, tobacco, and drug use during pregnancy can cause a range of adverse birth outcomes. Promoting family planning among women with substance use disorders (SUD) can help reduce substance exposed pregnancies.
OBJECTIVES: We conducted qualitative research to determine the acceptability and feasibility of offering family planning education and services SUD treatment centers.
METHODS: Focus groups and in-depth interviews were conducted with clients, staff and medical providers at three treatment centers. Interviews were transcribed and data was analyzed using a flexible coding scheme.
RESULTS: Clients reported being interested in family planning services while they were in treatment. Most preferred to receive these services onsite. Providers also felt that services should be received onsite, though cited several barriers to implementation, including time constraints and staff levels of comfort with the subject. CONCLUSIONS/IMPORTANCE: Women in SUD treatment are open to the integration of family planning services into treatment. Treatment centers have the opportunity to serve as models of client-centered health homes that offer a variety of educational, preventive, and medical services for women in both treatment and recovery.

Entities:  

Keywords:  Contraception; family planning; qualitative research; substance-exposed pregnancy; treatment; women

Mesh:

Year:  2016        PMID: 27440391     DOI: 10.1080/10826084.2016.1188944

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  9 in total

1.  Perceptions of Pregnancy and Contraceptive Use: An In-Depth Study of Women in Los Angeles Methadone Clinics.

Authors:  Marta Bornstein; Jessica D Gipson; Roselle Bleck; Aparna Sridhar; Agatha Berger
Journal:  Womens Health Issues       Date:  2018-11-13

2.  Innovative approaches to reduce unintended pregnancy and improve access to contraception among women who use opioids.

Authors:  Sarah H Heil; Heidi S Melbostad; Catalina N Rey
Journal:  Prev Med       Date:  2019-08-06       Impact factor: 4.018

3.  Ethical Issues in Providing and Promoting Contraception to Women with Opioid Use Disorder.

Authors:  Nadia Abbass; Tani Malhotra; Brooke Bullington
Journal:  J Clin Ethics       Date:  2022

4.  Contraceptive Knowledge among Females and Males Receiving Medication Treatment for Opioid Use Disorder Compared to Those Seeking Primary Care.

Authors:  Heidi S Melbostad; Gary J Badger; Catalina N Rey; Lauren K MacAfee; Anne K Dougherty; Stacey C Sigmon; Sarah H Heil
Journal:  Subst Use Misuse       Date:  2020-10-05       Impact factor: 2.164

5.  Virtually possible: using telehealth to bring reproductive health care to women with opioid use disorder in rural Maine.

Authors:  Terri-Ann Thompson; Katherine A Ahrens; Leah Coplon
Journal:  Mhealth       Date:  2020-10-05

6.  Understanding Contraceptive Needs of Women Who Inject Drugs in Orange County: A Qualitative Study.

Authors:  Orli K Florsheim; Dallas Augustine; Megan M Van Ligten; Heike Thiel de Bocanegra; Rachel Perry
Journal:  J Addict Med       Date:  2021 Nov-Dec 01       Impact factor: 3.702

7.  Miscarriage and Abortion Among Women Attending Harm Reduction Services in Philadelphia: Correlations With Individual, Interpersonal, and Structural Factors.

Authors:  Joy D Scheidell; Janna Ataiants; Stephen E Lankenau
Journal:  Subst Use Misuse       Date:  2022-03-11       Impact factor: 2.362

8.  Let's talk about sex: Discourses on sexual relations, sugar dating and "prostitution-like" behaviour in drug treatment for young people.

Authors:  Ditte Andersen; Ida Friis Thing
Journal:  Nordisk Alkohol Nark       Date:  2021-06-24

9.  Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse.

Authors:  Stephani L Stancil; Melissa K Miller; Alex Duello; Sarah Finocchario-Kessler; Kathy Goggin; Rachel P Winograd; Emily A Hurley
Journal:  Harm Reduct J       Date:  2021-08-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.